Medicare AdvantageCoverageMedium impact

Blue Medicare Announcement

Q: Who is affected by this change?

This affects Arkansas Blue Cross Blue Shield Endocrinology, Family Medicine, Internal Medicine providers in AR on Medicare Advantage plans.

Arkansas Blue Cross Blue Shield·AR · Endocrinology, Family Medicine, Internal Medicine·Medical Policy

Effective date

Not stated

We identified it

Jun 19, 2026

Days to comply

—

Summary

Arkansas Blue Medicare changed their 2026 preferred Continuous Glucose Monitor (CGM) manufacturer to Dexcom. Providers must send new Dexcom CGM prescriptions within 3 business days for patients currently using other manufacturers' CGMs to ensure continuity of care.

Action Required

Action needed

Within 3 business days: Providers must identify all Arkansas Blue Medicare patients currently using non-Dexcom CGMs and send new prescriptions for Dexcom CGMs to the patient's pharmacy. Contact medicarerx@arkbluecross.com with questions. Failure to act may result in coverage issues for patients' CGM supplies.

Related policy hubs

Arkansas Blue Cross Blue Shield policies AR policy changes Endocrinology Family Medicine Internal Medicine